This is a Validated Antibody Database (VAD) review about rat Mi 2 autoantigen, based on 5 published articles (read how Labome selects the articles), using Mi 2 autoantigen antibody in all methods. It is aimed to help Labome visitors find the most suited Mi 2 autoantigen antibody. Please note the number of articles fluctuates since newly identified citations are added and citations for discontinued catalog numbers are removed regularly.
Mi 2 autoantigen synonym: Mi-2

Santa Cruz Biotechnology
mouse monoclonal (B-4)
  • western blot; human; loading ...; fig s1
Santa Cruz Biotechnology Mi 2 autoantigen antibody (Santa Cruz Biotechnology, sc-55606) was used in western blot on human samples (fig s1). Nucleic Acids Res (2017) ncbi
Cell Signaling Technology
domestic rabbit monoclonal (D4B7)
  • immunohistochemistry - paraffin section; human; 1:400; loading ...; fig 6b
  • chromatin immunoprecipitation; human; 1:50; loading ...; fig 6d
Cell Signaling Technology Mi 2 autoantigen antibody (CST, 12011s) was used in immunohistochemistry - paraffin section on human samples at 1:400 (fig 6b) and in chromatin immunoprecipitation on human samples at 1:50 (fig 6d). Br J Cancer (2022) ncbi
domestic rabbit monoclonal (D4B7)
  • western blot; human; 1:1000; fig 5e
Cell Signaling Technology Mi 2 autoantigen antibody (Cell Signaling Technology, 12011S) was used in western blot on human samples at 1:1000 (fig 5e). Cancer Res (2021) ncbi
domestic rabbit monoclonal (D8B12)
  • western blot; mouse; loading ...; fig 1a
Cell Signaling Technology Mi 2 autoantigen antibody (CST, 11912) was used in western blot on mouse samples (fig 1a). Cell Rep (2019) ncbi
domestic rabbit monoclonal (D4B7)
  • western blot; human; loading ...; fig 2c
Cell Signaling Technology Mi 2 autoantigen antibody (CST, 12011) was used in western blot on human samples (fig 2c). Genes Dev (2017) ncbi
Articles Reviewed
  1. Yan W, Han Q, Gong L, Zhan X, Li W, Guo Z, et al. MBD3 promotes hepatocellular carcinoma progression and metastasis through negative regulation of tumour suppressor TFPI2. Br J Cancer. 2022;: pubmed publisher
  2. Zhao Z, Szczepanski A, Tsuboyama N, Abdala Valencia H, Goo Y, Singer B, et al. PAX9 Determines Epigenetic State Transition and Cell Fate in Cancer. Cancer Res. 2021;81:4696-4708 pubmed publisher
  3. Yen W, Sharma R, Cols M, Lau C, Chaudhry A, Chowdhury P, et al. Distinct Requirements of CHD4 during B Cell Development and Antibody Response. Cell Rep. 2019;27:1472-1486.e5 pubmed publisher
  4. Morgan M, Rickels R, Collings C, He X, Cao K, Herz H, et al. A cryptic Tudor domain links BRWD2/PHIP to COMPASS-mediated histone H3K4 methylation. Genes Dev. 2017;31:2003-2014 pubmed publisher
  5. Blank M, Chen S, Poetz F, Schnolzer M, Voit R, Grummt I. SIRT7-dependent deacetylation of CDK9 activates RNA polymerase II transcription. Nucleic Acids Res. 2017;45:2675-2686 pubmed publisher